Duvall Diantha

CHIEF FINANCIAL OFFICER at GENOCEA BIOSCIENCES, INC.; Chief Accounting Officer at Bioverativ Inc.

Sold, on record
$56k
Dollars the filings state
Form 4 sales
5
Latest Jun 2, 2022
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Bioverativ Inc.Unusual
    Jun 28, 2017 2017

    Sold 818 shares at $60.47 ($49k)

    Duvall Diantha, Chief Accounting Officer

    Sold 27.8% of holdings ($178k position)2,128 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale GENOCEA BIOSCIENCES, INC.Plan not stated
    Mar 16, 2022 +1722 days

    Sold 2,873 shares at $1.10 ($3k)

    Duvall Diantha, CHIEF FINANCIAL OFFICER

    Sold 3% of holdings ($105k position)92,738 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale GENOCEA BIOSCIENCES, INC.Plan not stated
    Apr 4, 2022 +19 days

    Sold 963 shares at $1.25 ($1k)

    Duvall Diantha, CHIEF FINANCIAL OFFICER

    Sold 1% of holdings ($116k position)91,775 shares leftFiling

  4. 4 Form 4 sale GENOCEA BIOSCIENCES, INC.Plan not stated
    May 26, 2022 +52 days

    Sold 24,407 shares at $0.0800 ($2k)

    Duvall Diantha, CHIEF FINANCIAL OFFICER

    Sold 24.1% of holdings ($8k position)76,743 shares leftFiling

  5. 5 Form 4 sale GENOCEA BIOSCIENCES, INC.Plan not stated
    Jun 2, 2022 +7 days

    Sold 1,355 shares at $0.0600 ($81)

    Duvall Diantha, CHIEF FINANCIAL OFFICER

    Sold 1.8% of holdings ($5k position)75,388 shares left0.5x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (5)

Form 144 notices and Form 4 sales by Duvall Diantha
Source
Jun 2, 2022Jun 3, 2022GENOCEA BIOSCIENCES, INC.CHIEF FINANCIAL OFFICERForm 4 sale1,355$811.8%Plan not statedSEC
May 26, 2022May 26, 2022GENOCEA BIOSCIENCES, INC.CHIEF FINANCIAL OFFICERForm 4 sale24,407$2k24.1%Plan not statedSEC
Apr 4, 2022Apr 5, 2022GENOCEA BIOSCIENCES, INC.CHIEF FINANCIAL OFFICERForm 4 sale963$1k1.0%Plan not statedSEC
Mar 16, 2022Mar 17, 2022GENOCEA BIOSCIENCES, INC.CHIEF FINANCIAL OFFICERForm 4 sale2,873$3k3.0%Plan not statedSEC
Jun 28, 2017Jun 29, 2017Bioverativ Inc.Chief Accounting OfficerForm 4 sale818$49k27.8%UnusualSEC